Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 9 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SemiLEDs Corp | 103,571 | reported | 20 Feb 2012 | tx 3+103,571−53,571 |
| Processa Pharmaceuticals, Inc. | 17,131 | reported | 29 May 2026 | tx 53+3,543,129−20,168 |
| QUESTCOR PHARMACEUTICALS INC | 0 | reported | 14 Aug 2014 | tx 88+1,235,782−1,117,950 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | PURCHASE | Processa Pharmaceuticals, Inc. | 1,786 | 2.57 USD | |
| 15 May 2026 | PURCHASE | Processa Pharmaceuticals, Inc. | 1,545 | 2.97 USD | first after silence |
| 01 Jan 2026 | EXERCISE | Processa Pharmaceuticals, Inc. | 49 | 0.00 USD | |
| 01 Jan 2026 | EXERCISE | Processa Pharmaceuticals, Inc. | 49 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 111,000 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 333,000 | 0.00 USD | deriv |
| 24 Jul 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 1,813,133 | 0.00 USD | deriv |
| 01 Apr 2025 | TAX_WITHHOLDING | Processa Pharmaceuticals, Inc. | 5,345 | 0.41 USD | |
| 01 Apr 2025 | EXERCISE | Processa Pharmaceuticals, Inc. | 17,272 | — | |
| 27 Jan 2025 | PURCHASE | Processa Pharmaceuticals, Inc. | 124,500 | 0.80 USD | |
| 05 Apr 2024 | EXERCISE | Processa Pharmaceuticals, Inc. | 1,675 | — | |
| 10 Jul 2024 | TAX_WITHHOLDING | Processa Pharmaceuticals, Inc. | 282 | 1.71 USD | |
| 10 Jul 2024 | EXERCISE | Processa Pharmaceuticals, Inc. | 644 | — | |
| 05 Apr 2024 | TAX_WITHHOLDING | Processa Pharmaceuticals, Inc. | 518 | 2.79 USD | |
| 28 Jun 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 404 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 404 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 3,233 | 0.00 USD | deriv |
| 28 Jun 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 2,425 | 0.00 USD | deriv |
| 01 Jan 2024 | TAX_WITHHOLDING | Processa Pharmaceuticals, Inc. | 518 | 2.79 USD | |
| 01 Jan 2024 | EXERCISE | Processa Pharmaceuticals, Inc. | 1,675 | — | |
| 01 Jan 2024 | EXERCISE | Processa Pharmaceuticals, Inc. | 1,675 | 0.00 USD | deriv |
| 07 Feb 2024 | PURCHASE | Processa Pharmaceuticals, Inc. | 21,000 | 2.45 USD | |
| 06 Feb 2024 | PURCHASE | Processa Pharmaceuticals, Inc. | 20,000 | 2.53 USD | |
| 12 Oct 2023 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 155,277 | 0.29 USD | |
| 10 Oct 2023 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 142,000 | 0.24 USD |
2 purchases reported after at least 12 months of silence — most recent on 15 May 2026.